NCT00785512

A Study on the Long-term Efficacy of Nebivolol After Withdrawal of Therapy

A Prospective, Randomized, Double-Blind, Placebo Controlled Study of the Long-Term Efficacy of Nebivolol in Hypertensive Patients After Withdrawal of Therapy

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 207 (actual)
• Sponsor: Forest Laboratories · Industry
• Sex: All
• Age: 18 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

This study will evaluate the long-term efficacy of nebivolol monotherapy in patients with stage 1 or stage 2 hypertension after the withdrawal of active medication.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	Nebivolol	Nebivolol 10 mg, 10-mg Nebivolol nontrade tablets , oral administration Nebivolol 20 mg, 20-mg Nebivolol nontrade tablets , oral administration Nebivolol 40 mg, two 20-mg Nebivolol nontrade tablets , oral administration
DRUG	Placebo	Matching placebo tablets, oral administration

Timeline

• Start date: 2008-11-01
• Primary completion: 2009-08-01
• First posted: 2008-11-05
• Last updated: 2010-09-15
• Results posted: 2010-09-15

Locations

26 sites across 1 country: United States